20354 Federal Register / Vol. 72, No. 78 / Tuesday April 24, 2007 / Notices 

Name of Committee: Integrative, 

Functional and Cognitive Neuroscience 

Integrated Review Group; Neurotoxicology 

and Alcohol Study Section. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Churchill Hotel, 1914 Connecticut 

Avenue, NW., Washington, DC 20009. 

Contact Person: Joseph G. Rudolph, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7844, Bethesda, MD 20892, 301–435–

2212, josephru@csr.nih.gov. 

Name of Committee: Health of the 

Population Integrated Review Group; 

Epidemiology of Cancer Study Section. 

Date: June 14–15, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Admiral Fell Inn, 888 South 

Broadway, Baltimore, MD 21231. 

Contact Person: Denise Wiesch, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892, (301) 435–

0684, wieschd@csr.nih.gov. 

Name of Committee: Immunology 

Integrated Review Group; Immunity and Host 

Defense Study Section. 

Date: June 14–15, 2007. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Washington Plaza Hotel, 10 Thomas 

Circle, NW., Washington, DC 20005. 

Contact Person: Patrick K. Lai, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2215, 

MSC 7812, Bethesda, MD 20892, 301–435–

1052, laip@csr.nih.gov. 

Name of Committee: Molecular, Cellular 

and Developmental Neuroscience Integrated 

Review Group; Neurogenesis and Cell Fate 

Study Section. 

Date: June 14–15, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Washington, DC 20037. 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7850, Bethesda, MD 20892, (301) 435–

1257, baizerl@csr.nih.gov. 

Name of Committee: Biological Chemistry 

and Macromolecular Biophysics Integrated 

Review Group; Synthetic and Biological 

Chemistry B Study Section. 

Date: June 14–15, 2007. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree Hotel, 8120 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Mike Radtke, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4176, 

MSC 7806, Bethesda, MD 20892, 301–435–

1728, radtkem@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: April 17, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–2035 Filed 4–23–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Opioid Drugs in Maintenance and 

Detoxification Treatment of Opiate 

Addiction; Public Notice of Revocation 

of Certification 

AGENCY: Substance Abuse and Mental 

Health Services Administration 

(SAMHSA), Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The Substance Abuse and 

Mental Health Services Administration 

has revoked the certification to provide 

opioid assisted treatment for the three 

opioid treatment programs listed below. 

DATES: The revocation of certification 

was effective on March 20, 2007. 

FOR FURTHER INFORMATION CONTACT: 

Nicholas Reuter, Center for Substance 

Abuse Treatment (CSAT), Division of 

Pharmacologic Therapies, SAMHSA, 

One Choke Cherry Road, Rm 2–1063, 

Rockville, MD 20857, (240) 276–2716, email: Nicholas.Reuter@samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

In a notice published in the Federal 

Register of January 17, 2001 (66 FR 

4076, January 17, 2001), the Substance 

Abuse and Mental health Services 

Administration (SAMHSA) issued final 

regulations for the use of narcotic drugs 

in maintenance and detoxification 

treatment of opioid addiction. That final 

rule established an accreditation-based 

regulatory system under 42 CFR part 8 

(‘‘Certification of Opioid Treatment 

Programs,’’ ‘‘OTPs’’). The SAMHSA 

regulations establish the standards for 

determining that practitioners 

(programs) are qualified for Drug 

Enforcement Administration (DEA) 

registration under 21 U.S.C. 821(g)(1). 

Qualified programs are granted 

certification. 

The regulations establish the 

conditions for certification as well as 

the criteria for the suspension or 

revocation of SAMHSA certification. In 

addition, Subpart C sets forth the 

procedures for review of suspension or 

proposed revocation of OTP 

certification. 

The Administrator of SAMHSA 

proposed to decertify these three 

programs in August 2006. As set forth 

under 42 CFR part 8, subpart C, each 

OTP requested a review of the 

Administrator’s proposal, and submitted 

documents and briefs to a designated 

reviewing official for consideration, that 

were incorporated into an 

administrative review record. After 

considering the available information 

and evidence, the reviewing officials, in 

upholding the Administrator’s proposal 

to revoke certification, found that the 

OTPs listed below were in violation of 

Federal Opioid Treatment Program 

Regulations (42 CFR § 8.11,8.14). 

1. New Horizon Rehabilitation 

Services, 4809 W. Chicago Ave., 

Chicago, IL 60651. 

2. Turning Point Treatment Center, 

Inc., 210 Commerce St., Blairsville, 

Georgia 30512. 

3. Bay Area C.A.R.E. Center, Inc., 

3138 South Alameda, Corpus Christi, 

Texas 78404. 

Dated: April 13, 2007. 

Terry L. Cline, 

Administrator, Substance Abuse and Mental 

Health Services Administration. 

[FR Doc. 07–1994 Filed 4–23–07; 8:45 am] 

BILLING CODE 4160–20–M 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5117–N–34] 

Notice of Submission of Proposed 

Information Collection to OMB; 

Servicemembers Civil Relief 

AGENCY: Office of the Chief Information 

Officer, HUD. 

ACTION: Notice. 

SUMMARY: The proposed information 

collection requirement described below 

has been submitted to the Office of 

Management and Budget (OMB) for 

review, as required by the Paperwork 

Reduction Act. The Department is 

soliciting public comments on the 

subject proposal. 

Federal law requires lenders to send 

a statement or notice to homeowners in 

default explaining the mortgage and 

foreclosure rights of servicemembers 

and their dependents under the 

Servicemembers Civil Relief Act (50 


jlentini on PROD1PC65 with NOTICES